Study Stopped
unable to recruit patients
Manual and Expressed Placental Removal at Cesarean Delivery and Its Effects on Various Cardiac Indices
1 other identifier
interventional
19
1 country
1
Brief Summary
The purpose of this study is to evaluate whether manual removal of the placenta during a cesarean delivery results in higher changes in the resistance of blood flow throughout the body, also called systemic vascular resistance (SVR)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pregnancy
Started Jul 2008
Typical duration for not_applicable pregnancy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 2, 2008
CompletedFirst Posted
Study publicly available on registry
July 8, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedJuly 16, 2012
July 1, 2012
2.6 years
July 2, 2008
July 12, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hemodynamic profile, especially Systemic Vascular Resistance
immediately before and 24 hours after cesarean delivery
Secondary Outcomes (1)
development of postpartum preeclampsia
within 1 week of delivery
Study Arms (2)
manual
ACTIVE COMPARATORManual removal of placenta
expressed
ACTIVE COMPARATORexpressed placental removal
Interventions
Manual removal of placenta during cesarean delivery
Surgeon will perform an expressed delivery of the placenta
Eligibility Criteria
You may qualify if:
- pregnant
- scheduled for cesarean delivery
- able to give informed consent
You may not qualify if:
- taking medications that may affect hemodynamics
- unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
William Beaumont Hospital
Royal Oak, Michigan, 48073, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian Bogner, MD
Corewell Health East
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
July 2, 2008
First Posted
July 8, 2008
Study Start
July 1, 2008
Primary Completion
February 1, 2011
Study Completion
January 1, 2012
Last Updated
July 16, 2012
Record last verified: 2012-07